Phase I/II trial of PD-1 antibody nivolumab with peptide vaccine in patients naive to or that failed ipilimumab.
暂无分享,去创建一个
G. Gibney | J. Weber | R. Kudchadkar | A. Sarnaik | Ann Chen | Wenshi Wang | J. Kroeger | Xiuhua Zhao | Bin Yu | R. Conti | Alberto J. Martinez | Cabell Eysmans | Donna Gallenstein | Alberto J Martinez